• 1
    Committee on the Safety of Medicines. Medicines newly released for self-medication. Curr Prob Pharmacovigil 1994; 20: 44.
  • 2
    Mason P. Has reclassification of GI drugs changed the treatment of disease? Pharmaceut J 1996; 257: 7312.
  • 3
    Reilly TG, Mann SG, Panos MZ, Walt RP. Low-dose famotidine and cimetidine in single post-prandial doses: a placebo controlled comparative study of overnight pH. Gut 1995; 37: 3258.
  • 4
    Reilly TG, Singh S, Cotterel J, et al.Low-dose famotidine and ranitidine as single post-prandial doses: a 3-period placebo-controlled comparative trial. Aliment Pharmacol Ther 1996; 10: 74955.
  • 5
    Grimley CE, Cotterel J, Mann SG, et al.Nocturnal intragastric acidity after over-the-counter doses of famotidine, ranitidine or placebo. Aliment Pharmacol Ther 1997; 11: 8815.
  • 6
    Grimley CE, West JM, Loft DE, et al. Early and late effects of low-dose famotidine, ranitidine or placebo. Aliment Pharmacol Ther 1996; 10: 7437.
  • 7
    Merki H, Witzel L, Walt RP, et al. Day to day variation of 24 hour intragastric acidity. Gastroenterology 1988; 94: 88791.
  • 8
    Dammann HG, Dreyer M, Kangah R, Wolf N. Gastric aspiration technique for pH recording: a critical evaluation of this method. Dig Dis Sci 1990; 8(Suppl. 1): 39.
  • 9
    Pounder RE, Lanzon-Miller S, Smith JTL, et al. Royal Free Hospital protocol for 24-hour intragastric acidity and plasma gastrin concentration. Dig Dis Sci 1990; 8(Suppl. 1): 107.
  • 10
    Pounder RE & Prewett EJ. Gastric secretion in health and disease. In: Gustavsson S, Kumar D, Graham DY, eds. The Stomach, Vol. 3b. London: Churchill Livingston, 1992: 53–79.
  • 11
    Hunt RH, Cederberg C, Dent J, et al. Optimizing acid suppression for treatment of acid related diseases. Dig Dis Sci 1995; 40: 2449S.
  • 12
    Jones DB, Howden CW, Burget DW, Kerr GD, Hunt RH. Acid suppression in duodenal ulcer: a metanalysis to define optimal dosing with anti-secretory drugs. Gut 1987; 28: 11207.
  • 13
    Bates S, Sjoden PS, Fellenius J, Nyren O. Blocked and non-blocked acid secretion and reported pain in ulcer, non-ulcer dyspepsia and normal subjects. Gastroenterology 1989; 97: 37683.
  • 14
    Mann SG, Murakami A, McCarroll K, et al. Low-dose famotidine in the prevention of sleep disturbance caused by heartburn after an evening meal. Aliment Pharmacol Ther 1995; 9: 395401.
  • 15
    Mann SG, Cottrell J, Murakami A, Stauffer L, Rao AN. Prevention of heartburn relapse by low-dose famotidine: a test meal model for duration of symptom control. Aliment Pharmacol Ther 1997; 11: 1217.
  • 16
    McIsaac R, Ciociola A, Balderson D, Pappa K, Yin Y, Giefer E. Night-time intragastric acidity following ranitidine and low-dose famotidine. Digestion 1998; 59(Suppl. 3): 258(A2189)258(A2189).